SynthesisAnnals of hematology2025

The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.

Laiba Shakeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.